Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
Authors
Keywords
CD15/FUT4, EGFR or VEGF, ERBB3 or FGFR4, Metastatic CRC
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-01
DOI
10.1186/s13046-015-0225-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Emerging Role of Neutrophil to Lymphocyte Ratio in Determining Colorectal Cancer Treatment Outcomes: A Systematic Review and Meta-Analysis
- (2014) George Malietzis et al. ANNALS OF SURGICAL ONCOLOGY
- Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling
- (2014) M. Schoumacher et al. CANCER RESEARCH
- Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
- (2014) Gunnar Steinert et al. CANCER RESEARCH
- Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition
- (2014) T. Troiani et al. CLINICAL CANCER RESEARCH
- The immune contexture of primary and metastatic human tumours
- (2014) Nicolas A Giraldo et al. CURRENT OPINION IN IMMUNOLOGY
- In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer
- (2014) Daniel A Sussman et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2014) S. Misale et al. Science Translational Medicine
- Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
- (2014) Chong Sun et al. Cell Reports
- Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
- (2014) Massimo Pancione et al. Journal of Immunology Research
- Detailed analysis of inflammatory cell infiltration in colorectal cancer
- (2013) J P Väyrynen et al. BRITISH JOURNAL OF CANCER
- The Role of IL-1 in the Early Tumor Cell-Induced Angiogenic Response
- (2013) Y. Carmi et al. JOURNAL OF IMMUNOLOGY
- The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22
- (2013) Massimo Pancione et al. Journal of Translational Medicine
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor
- (2013) Raoul A. Droeser et al. PLoS One
- Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPARγ and TNFα Signaling
- (2013) Stefano Maria Pagnotta et al. PLoS One
- Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b
- (2013) G. Curtale et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- On the cytokines produced by human neutrophils in tumors
- (2013) Cristina Tecchio et al. SEMINARS IN CANCER BIOLOGY
- Immunomonitoring and prognostic relevance of neutrophils in clinical trials
- (2013) Frede Donskov SEMINARS IN CANCER BIOLOGY
- FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway
- (2013) L Cheng et al. Cell Death & Disease
- Emerging VEGF-receptor inhibitors for colorectal cancer
- (2012) Erika Martinelli et al. EXPERT OPINION ON EMERGING DRUGS
- Panitumumab: a summary of clinical development in colorectal cancer and future directions
- (2012) Guillem Argiles et al. Future Oncology
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
- (2009) J. Joshua Smith et al. GASTROENTEROLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now